Off-label use of an automated insulin delivery system in pregnant women with type 1 diabetes.

Diabetes Res Clin Pract

Endocrinology and Nutrition Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208 Sabadell, Barcelona, Spain.

Published: August 2023

Using commercially available automated insulin delivery (AID) systems for treating type 1 diabetes during pregnancy remains controversial. This retrospective study assessed six pregnant women with type 1 diabetes who underwent AID therapy. Our observations revealed that AID treatment, in most cases, did not achieve the desired glycemic targets for pregnancy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2023.110800DOI Listing

Publication Analysis

Top Keywords

type diabetes
12
automated insulin
8
insulin delivery
8
pregnant women
8
women type
8
off-label automated
4
delivery system
4
system pregnant
4
diabetes commercially
4
commercially automated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!